A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the effectiveness of CP-868,596 + docetaxel, AG-013736 + docetaxel and
CP-868,596 + AG-013736 + docetaxel in patients previously treated for non-small cell lung
cancer.